Announcements Trials
Browse Landscape

Phase

Phase 1 3Phase 1/2 1

Status

Completed 3Terminated 1

Sponsor Class

INDUSTRY 4OTHER 3

Study Type

Interventional 4

Sponsor

Cancer Type

Lymphoid 5Tumor-Agnostic 4Other hematologic neoplasm 2Other solid neoplasm 1Dermatologic 1

Conditions

Neoplasms 3Neoplasm Metastasis 1

Interventions

pembrolizumab 62Paclitaxel 51Gemcitabine 50Carboplatin 45Docetaxel 43Cisplatin 31Pemetrexed 30Nivolumab 28Bevacizumab 28atezolizumab 22Fluorouracil 22Cetuximab 21Capecitabine 21Irinotecan 20Leucovorin 19Afatinib 18Erlotinib Hydrochloride 15trametinib 14Trastuzumab 13Ipilimumab 13130-nm albumin-bound paclitaxel 13regorafenib 11olaparib 11Sorafenib 11Oxaliplatin 11Drug Therapy 11eribulin 10enzalutamide 10Midazolam 10Injections 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
INDUSTRY × Ketoconazole × Tumor-Agnostic × Clear all
NCT01340846 2017-11-13

A Pharmacokinetics Study of the Effects of GSK2118436 on Warfarin, the Effects of Ketoconazole and Gemfibrozil on GSK2118436, and the Effects of Repeat Doses of GSK2118436 in Subjects With BRAF Mutant Solid Tumors

GlaxoSmithKline

Phase 1 Completed
48 enrolled
Tumor-Agnostic

Neoplasms

NCT01267084 2015-10-14

A Study to Assess the Potential Effects of Ketoconazole on the Pharmacokinetics of Trabectedin in Patients With Advanced Malignancies

Janssen Research & Development, LLC

Phase 1/2 Completed
12 enrolled
Tumor-Agnostic

Neoplasm Metastasis

NCT01000376 2013-09-23

Evaluating the Pharmacokinetics and Tolerance of Co-administration of Oral Multiple Dose of Ketoconazole and an IV (Bolus) Infusion of Eribulin in Patients With Advanced Solid Tumors

Eisai Inc.

Phase 1 Completed
12 enrolled 9 charts
Tumor-Agnostic

Neoplasms

NCT00162214 2011-04-14

Study of Dasatinib in Patients With Advanced Solid Tumors

Bristol-Myers Squibb

Phase 1 Terminated
60 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡